News | Analytics Software | October 06, 2015

HealthMyne Inc. and Moffitt Cancer Center Sign Imaging Analytics Technology Agreement

Deal will create structured, mineable repository of de-identified thoracic tumor descriptors to evaluate samples for imaging biomarkers

HealthMyne Inc, Moffitt Cancer Center, imaging analytics technology agreement, thoracic oncology

Image courtesy of Siemens Healthcare

October 6, 2015 — HealthMyne Inc., a clinical imaging informatics company, has agreed to a research and product evaluation agreement with Moffitt Cancer Center. The primary objective of the agreement is the implementation of an imaging analytics software platform, with an initial focus on thoracic oncology.

One important component of the technology agreement is a structured, mineable repository of de-identified tumor descriptors that will allow investigators to evaluate samples for imaging biomarkers.  “The tumor characterization and data mining capabilities that the HealthMyne solution provides will help to accelerate our efforts to identify and validate important radiomic signatures,” said Robert J. Gillies, Ph.D., chair of the Department of Cancer Imaging and Metabolism at Moffitt.  “We have moved from viewing images as pictures to seeing them as data, and that is a very empowering clinical care step.”

For more information: www.healthmyne.com

Related Content

These MRI scans show diffuse white matter abnormality (DWMA). The top three panels display raw MRI images from very preterm infants born at 27 weeks (left), 26 weeks (center) and 31 weeks (right) gestation.

These MRI scans show diffuse white matter abnormality (DWMA). The top three panels display raw MRI images from very preterm infants born at 27 weeks (left), 26 weeks (center) and 31 weeks (right) gestation. Higher signal intensity can be seen in the central white matter, particularly for the 31-week gestation infant. The bottom panels display the corresponding slices with objectively segmented DWMA in yellow. The 27-week infant (left) was diagnosed with mild DWMA, the 26-week infant (center) was diagnosed with moderate DWMA, and the 31-week infant had severe DWMA. Image courtesy of Cincinnati Children's and Nature Scientific Reports

News | Magnetic Resonance Imaging (MRI) | October 01, 2020
October 1, 2020 — As many as 70% of very premature infants (born earlier than 32 weeks gestation) show signs of white
Siemens Healthineers has introduced a new version of its c.cam dedicated cardiac nuclear medicine system to the U.S. market. This single-photon emission computed tomography (SPECT) scanner with a reclining patient chair offers nuclear cardiology providers a low total cost of ownership, ease of installation, and a high level of image quality.
News | SPECT Imaging | September 30, 2020
September 30, 2020 — Siemens Healthineers h
Lung and respiratory health pioneer paves way for more precise care of complex respiratory conditions
News | Artificial Intelligence | September 25, 2020
September 25, 2020 — VIDA Diagnostics, Inc. announced that it has received 510(k) clearance from the Food and Drug Ad
Philips Azurion Lung Edition supports high precision diagnosis and minimally invasive therapy in one room
News | Lung Imaging | September 21, 2020
September 21, 2020 — Philips introduced...